Valganciclovir Powder, For Solution
Product Images NDC 62332-754

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 62332-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovir-t1-formula.jpg (Valganciclovir T1 Formula)

This image shows formulas for calculating Mosteller Body Surface Area (BSA) in square meters and Schwartz Creatinine Clearance in milliliters per minute per 1.73 square meters, important for dosing and kidney function assessment. The BSA is calculated as the square root of (Height in cm times Weight in kg divided by 3600). Schwartz Creatinine Clearance is calculated as k times Height in cm divided by Serum Creatinine in mg/dL.*

FDA Label Image

Valganciclovir-t2-formula.jpg (Valganciclovir T2 Formula)

This image shows a mathematical formula for calculating a value based on age, body weight, and serum creatinine levels, with a gender adjustment factor. It provides the calculation separately for males and females, where the female value is 0.85 times the male value.*

FDA Label Image

Valganciclovir-str.jpg (Valganciclovir Str)

Chemical structure of valganciclovir hydrochloride, showing the molecular arrangement including the purine base, ester side chain, and hydrochloride salt.*

FDA Label Image

Valganciclovir-figr1.jpg (Valganciclovir Figr1)

An instructional diagram showing the components of an oral dispenser and bottle assembly for oral liquid medication. It labels the child resistant cap, bottle adapter, and bottle on the left side, and the plunger, barrel with volume markings, and tip of the oral dispenser on the right side.*

FDA Label Image

Valganciclovir-step-1.jpg (Valganciclovir Step 1)

An instructional illustration showing a hand holding a bottle with the instruction to "Shake well." The image demonstrates proper handling of an oral powder for solution medication before use.*

FDA Label Image

Valganciclovir-step-2.jpg (Valganciclovir Step 2)

An instructional diagram depicting the process of securing a cap onto a bottle. The image shows a bottle with a cap above it, accompanied by an arrow pointing downward and a circular arrow indicating a twisting motion to fasten the cap.*

FDA Label Image

Valganciclovir-step-3.jpg (Valganciclovir Step 3)

Illustration showing an oral syringe with volume markings from 2 mL to 10 mL. A labeled arrow points to the syringe barrel, identifying it as a dosage indicator measured in milliliters (mL). This image is likely related to dosing measurement for oral solution forms of medication.*

FDA Label Image

Valganciclovir-step-4.jpg (Valganciclovir Step 4)

An instructional illustration showing a hand pressing down on the plunger of a syringe, indicating how to use the syringe to measure or administer medication.*

FDA Label Image

Valganciclovir-step-5.jpg (Valganciclovir Step 5)

An instructional illustration showing a hand holding a syringe above a bottle labeled as having a 'bottle adapter opening.' The syringe is positioned for insertion into the bottle, with a downward arrow indicating the motion. This image demonstrates how to use the bottle adapter opening for liquid withdrawal or dosing.*

FDA Label Image

Valganciclovir-step-6.jpg (Valganciclovir Step 6)

An instructional illustration demonstrating how to draw liquid from a bottle into a syringe. The top part shows a bottle inverted with the neck positioned above the syringe barrel. The syringe is marked with volume graduations from 2 mL up to 10 mL, with an arrow indicating measurement direction.*

FDA Label Image

Valganciclovir-step-7.jpg (Valganciclovir Step 7)

An instructional illustration showing a hand using a syringe to withdraw liquid from a bottle. The image demonstrates proper technique for drawing up medication or solution from the bottle, relevant to the oral powder for solution dosage form of Valganciclovir.*

FDA Label Image

Valganciclovir-step-8.jpg (Valganciclovir Step 8)

An instructional line drawing showing a person administering oral medication with a syringe to a child. The syringe is placed near the child's mouth for oral dosing.*

FDA Label Image

Valganciclovir-step-9.jpg (Valganciclovir Step 9)

An illustration depicting a bottle with a screw cap and an arrow indicating the direction to twist the cap, likely showing how to open the bottle.*

FDA Label Image

Valganciclovir-step10-1.jpg (Valganciclovir Step10 1)

An instructional illustration showing a water tap dripping drops of water into a medicine syringe, with additional water drops visible around the syringe. This likely depicts preparation steps involving adding water to the syringe, possibly for dissolving medication powder.*

FDA Label Image

Valganciclovir-step10-2.jpg (Valganciclovir Step10 2)

An illustration of a transparent syringe with measurement markings along the barrel, a plunger, and a tapered nozzle. The syringe is designed for oral administration but does not display any specific drug labeling or branding.*

FDA Label Image

Bottle Label (Valganciclovir Bl 50 mg Bottle)

Label for Valganciclovir for Oral Solution, USP 50 mg/mL, powder for solution manufactured by Alembic Pharmaceuticals Inc. The label indicates a 100 mL (3.4 fl oz) bottle, with storage instructions for dry powder and constituted solution, dosage information, and regulatory details including lot and expiration date fields.*

FDA Label Image

50 mg/ml (Valganciclovir50mg Carton)

Label for Valganciclovir for Oral Solution USP 50 mg/mL by Alembic Pharmaceuticals Inc. The label indicates a 100 mL (3.4 fl oz) powder for oral solution with Rx only status. It includes dosing instructions, storage conditions, NDC 62332-754-31, and manufacturer information. The design features blue and green stripes and the Alembic logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.